Category - Executive Moves

Executive Moves

Gerald Solensky resigns as Zomedica CEO; Shameze Rampertab named interim CEO

Gerald Solensky, Jr. has resigned as CEO, chairman and a director of Zomedica Pharmaceuticals (NYSE American, TSXV:ZOM), effective immediately. He will continue as a consultant to the company’s operating...

December 3, 2019

Executive Moves

Zenabis appoints finance expert Vincent Quan as director

Zenabis Global (TSX:ZENA) appointed Vincent Quan as a director of the company, effective immediately. Mr. Quan has more than 17 years of experience in corporate finance, specializing in the North American agriculture...

November 21, 2019

Executive Moves

Liminal BioSciences names Moira Daniels to head regulatory affairs, quality assurance

Liminal BioSciences (TSX:LMNL; OTCQX:LMNL) appointed Moira Daniels as the new head of regulatory affairs and quality assurance based at the company’s offices in Cambridge, UK. “Moira brings many years of global...

November 13, 2019

Executive Moves

Vireo Health names Bruce Linton as executive chairman

Vireo Health International (CNSX:VREO; OTCQX:VREOF) appointed Bruce Linton to the role of executive chairman, where he will serve as a director, work closely with Vireo CEO and founder, Dr. Kyle Kingsley, and spearhead...

November 7, 2019

Executive Moves

Ventripoint names Justin Leushner as CEO

Justin Leushner Ventripoint Diagnostics (TSXV:VPT; OTC:VPTDF) appointed Justin Leushner as CEO, replacing Dr. George Adams, who was elected chairman of the board. Mr. Leushner, who was named president of...

November 4, 2019

Executive Moves

Orthofix appoints Jon Serbousek as president and CEO

Jon Serbousek Orthofix Medical (NASDAQ:OFIX) appointed Jon Serbousek as president, CEO and a director of its board, effective immediately. Mr. Serbousek succeeds Brad Mason, who previously announced his retirement. Mr...

November 1, 2019

Executive Moves

Hepion appoints renowned liver disease expert, Dr. Stephen Harrison, as consultant medical director

Stephen Harrison Hepion Pharmaceuticals (NASDAQ:HEPA) appointed world-renowned Dr. Stephen Harrison as consultant medical director. Dr. Harrison is a peer-reviewer for more than 20 medical journals. He is...

October 10, 2019

Executive Moves

Anixa Biosciences names cancer vaccine pioneer, Dr. Ian Frazer to SAB

Ian Frazer Anixa Biosciences (NASDAQ:ANIX) appointed cancer vaccine pioneer, Dr. Ian Frazer, to its scientific advisory board. Dr. Frazer is a leading immunologist recognized as one of the first scientists to...

October 10, 2019

Executive Moves

Zosano Pharma names Steven Lo as CEO

Steven Lo Zosano Pharma (NASDAQ:ZSAN) has appointed Steven Lo as president, CEO and a director, effective Oct. 21. Mr. Lo is departing from his role as CCO at Puma Biotechnology (NASDAQ:PUMA), effective Oct. 18, where...

October 8, 2019

Executive Moves

Canaccord names veteran biotech analyst, Edward Nash, as managing director, equity research

Canaccord Genuity appointed Edward Nash as its New York office’s managing director, equity research. Mr. Nash completes Canaccord Genuity’s team of five senior biotechnology analysts and will focus on companies...

October 7, 2019

Category - Executive Moves

Gerald Solensky resigns as Zomedica CEO; Shameze Rampertab named interim CEO

Zenabis appoints finance expert Vincent Quan as director

Liminal BioSciences names Moira Daniels to head regulatory affairs, quality assurance

Vireo Health names Bruce Linton as executive chairman

Ventripoint names Justin Leushner as CEO

Orthofix appoints Jon Serbousek as president and CEO

Hepion appoints renowned liver disease expert, Dr. Stephen Harrison, as consultant medical director

Anixa Biosciences names cancer vaccine pioneer, Dr. Ian Frazer to SAB

Zosano Pharma names Steven Lo as CEO

Canaccord names veteran biotech analyst, Edward Nash, as managing director, equity research

General

More